These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38955414)

  • 1. HIV postexposure prophylaxis-in-pocket.
    Billick M; Bogoch II
    CMAJ; 2024 Jul; 196(24):E826. PubMed ID: 38955414
    [No Abstract]   [Full Text] [Related]  

  • 2. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.
    Tan DHS; Hull MW; Yoong D; Tremblay C; O'Byrne P; Thomas R; Kille J; Baril JG; Cox J; Giguere P; Harris M; Hughes C; MacPherson P; O'Donnell S; Reimer J; Singh A; Barrett L; Bogoch I; Jollimore J; Lambert G; Lebouche B; Metz G; Rogers T; Shafran S;
    CMAJ; 2017 Nov; 189(47):E1448-E1458. PubMed ID: 29180384
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket).
    Wood BR
    AIDS; 2020 Mar; 34(3):481-482. PubMed ID: 31996596
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV prevention with postexposure prophylaxis-in-pocket (PIP).
    Billick MJ; Sheps J; Bogoch II
    BMJ; 2023 Aug; 382():e076016. PubMed ID: 37532280
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes to Initial Postexposure Prophylaxis Regimens Between the Emergency Department and Clinic.
    Bogoch II; Siemieniuk RA; Andrews JR; Scully EP; Mayer KH; Bell CM; Zachary KC; Yawetz S
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):e182-4. PubMed ID: 25967272
    [No Abstract]   [Full Text] [Related]  

  • 6. Brief Report: Outcomes of Individuals Using HIV Postexposure Prophylaxis-In-Pocket ("PIP") for Low-Frequency, High-Risk Exposures in Toronto, Canada.
    Billick MJ; Fisher KN; Myers S; Tan DHS; Bogoch II
    J Acquir Immune Defic Syndr; 2023 Nov; 94(3):211-213. PubMed ID: 37850980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV Exposures.
    Tumarkin E; Heendeniya A; Murphy P; Placido T; Tan DHS; Bogoch II
    J Acquir Immune Defic Syndr; 2018 May; 78(1):20-22. PubMed ID: 29419570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When is postexposure prophylaxis recommended for needlestick?
    Matin M; Goldschmidt RH
    Am Fam Physician; 2011 Jun; 83(12):1374. PubMed ID: 21671536
    [No Abstract]   [Full Text] [Related]  

  • 9. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
    Jain S; Krakower DS; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV postexposure prophylaxis during the COVID-19 pandemic: experience from Madrid.
    Sánchez-Rubio J; Vélez-Díaz-Pallarés M; Rodríguez González C; Sanmartin Fenollera P; García Yubero C; García-Valdecasas MF
    Sex Transm Infect; 2021 Mar; 97(2):100. PubMed ID: 32680842
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV Postexposure Prophylaxis Starter Packs Were Not Designed to Help or Hinder Adherence.
    Zimmer R
    Clin Infect Dis; 2016 Mar; 62(5):667-8. PubMed ID: 26582746
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV seroconversion in a health care worker who underwent postexposure prophylaxis following needlestick injury.
    Borba Brum MC; Dantas Filho FF; Yates ZB; Verçoza Viana MC; Martin Chaves EB; Trindade DM
    Am J Infect Control; 2013 May; 41(5):471-2. PubMed ID: 23084562
    [No Abstract]   [Full Text] [Related]  

  • 13. Methods and Approaches to HIV Prevention.
    Balthazar MS
    J Assoc Nurses AIDS Care; 2017; 28(1):19-24. PubMed ID: 27751633
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of an Intervention to Increase Occupational Postexposure Prophylaxis in Sub-Saharan Africa.
    Courtenay-Quirk C; Selenic D; Lahuerta M; Kassa G; Murrman M; Bock N
    J Assoc Nurses AIDS Care; 2016; 27(5):727-30. PubMed ID: 27425796
    [No Abstract]   [Full Text] [Related]  

  • 15. Raltegravir-based HIV postexposure prophylaxis (PEP) in a real-life clinical setting: fewer drug-drug interactions (DDIs) with improved adherence and tolerability.
    Mulka L; Annandale D; Richardson C; Fisher M; Richardson D
    Sex Transm Infect; 2016 Mar; 92(2):107. PubMed ID: 26892929
    [No Abstract]   [Full Text] [Related]  

  • 16. CDC Releases Updated Guidelines for Postexposure Prophylaxis After Sexual, Injection Drug, or Other Nonoccupational Exposures to HIV.
    Goldschmidt RH
    Am Fam Physician; 2016 Sep; 94(5):392-3. PubMed ID: 27583430
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-exposure prophylaxis in the era of pre-exposure prophylaxis: a study of post-exposure prophylaxis use in South-East Queensland since the Pharmaceutical Benefits Scheme listing of pre-exposure prophylaxis.
    Biggs K; O'Sullivan M; Palmer C; McLellan J; Marple-Clark F; Spinks A; Langton-Lockton J; Thng C
    Int J STD AIDS; 2020 Apr; 31(5):426-431. PubMed ID: 32192371
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonoccupational postexposure HIV prophylaxis in sexual assault programs: a survey of SANE and FNE program coordinators.
    Draughon JE; Anderson JC; Hansen BR; Sheridan DJ
    J Assoc Nurses AIDS Care; 2014; 25(1 Suppl):S90-S100. PubMed ID: 24103741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Announcement: Updated Guidelines for Antiretroviral Postexposure Prophylaxis after Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV - United States, 2016.
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):458. PubMed ID: 27149423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate usage of post-exposure prophylaxis-in-pocket for HIV prevention by individuals with low-frequency exposures.
    Clifford Rashotte M; Yoong D; Naccarato M; Pico Espinosa OJ; Fisher K; Bogoch II; Tan DH
    Int J STD AIDS; 2024 May; 35(6):446-451. PubMed ID: 37963270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.